Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …

Molecular imaging, such as positron emission tomography (PET), is increasingly used as
biomarker to predict and assess treatment response in breast cancer. The number of …

This study aimed to compare CE-CT and 2-[18F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …

Female breast cancer (BC) is one of the most diagnosed cancers and causes of cancer-
related deaths in women, second only to lung cancer in Unites States. The American Cancer …

The advent of hybrid Positron Emission Tomography/Computed Tomography (PET/CT) and
PET/Magnetic Resonance Imaging (MRI) scanners resulted in an increased clinical …

The recent introduction of hybrid positron emission tomography/magnetic resonance
imaging (PET/MRI) as a promising imaging modality for breast cancer assessment has …

This study aimed to compare contrast-enhanced CT (CE-CT) and 18F-FDG PET/CT for
response monitoring in metastatic breast cancer using the standardized response …

Simple Summary The method of treatment evaluation in patients with chronic breast cancer
may affect clinical decision making and treatment protocols. In this study, we compared the …

Objective: This study was conducted to evaluate the usefulness of early assessment of tumor
response 18 using fluorine-18-fludeoxyglucose positron emission tomography/computed …

We compared the image quality and quantification parameters through bayesian penalized
likelihood reconstruction algorithm (Q. Clear) and ordered subset expectation maximization …